IGFBP3 and Alzheimer disease: The present results, along with inconsistency across previous conventional epidemiologic studies, suggest that any interventions aimed at increasing circulating IGF1/IGFBP3 to reduce AD risk may fail, and that these traits could be deselected as preventive AD candidates.